Global Bioprocess Validation Strategic Markets Report 2023: Market to Reach $622.6 Million by 2030 from $329.9 in 2022 - Digital Twins to Support Bioprocess Validation Market Growth

DUBLIN, Feb. 21, 2023 /PRNewswire/ -- The "Bioprocess Validation: Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering.

Global Bioprocess Validation Market to Reach $622.6 Million by 2030

In the changed post COVID-19 business landscape, the global market for Bioprocess Validation estimated at US$329.9 Million in the year 2022, is projected to reach a revised size of US$622.6 Million by 2030, growing at a CAGR of 8.3% over the analysis period 2022-2030.

Extractables / Leachables Testing Services, one of the segments analyzed in the report, is projected to record a 9% CAGR and reach US$255.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Integrity Testing Services segment is readjusted to a revised 8.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $121.7 Million, While China is Forecast to Grow at 11.4% CAGR

The Bioprocess Validation market in the U.S. is estimated at US$121.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$80.8 Million by the year 2030 trailing a CAGR of 11.4% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 7.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

What`s New for 2023?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year

Key Topics Covered:

MARKET OVERVIEW

• Impact of COVID-19 Pandemic and the Global Economic Update
• War & Inflation Supersede COVID-19 as Major Downside Risks for the Global Economy in 2023 & Beyond
• Here's How Inflationary Pressures Affect the Economy
• Russia-Ukraine War, the Primary Culprit Responsible for the Hardships
• Stubbornly High Inflation to Single Handedly Drag Down Global Growth
• Here's What's Causing the Current Spike in Inflation
• Pandemic Impact on Bioprocess Validation Market
• An Introduction to Bioprocess Validation
• Types of Process Validation
• Global Market Outlook
• Extractables/Leachables Testing Services: The Largest Segment
• Developed Regions Lead, Developing Economies Promise Future Growth
• Competition
• Competitive Market Presence - Strong/Active/Niche for Players Worldwide in 2023 (E)
• Recent Market Activity

FOCUS ON SELECT PLAYERS Select Competitors (Total 50 Featured)

• Almac Group
• Biozeen
• Cobetter Filtration Equipment Co., Ltd.
• Doc S.R.L.
• Eurofins Scientific
• Hangzhou Anow Microfiltration Co., Ltd.
• Meissner Filtration Products, Inc.
• Merck KGaA
• Pall Corporation (A Part of Danaher Corporation)
• Porvair PLC

MARKET TRENDS & DRIVERS

• Rapid Growth in Biopharmaceutical Production and Need to Prevent Product Contamination Necessitate Validation Services
• Increasing Pharma & Biotech Investments into Drug Development Activities Fuel Need for Bioprocess Validation
• Rise of Pharma Contract Manufacturing Present Growth Opportunities for Bioprocess Validation Outsourcing to Emerging Markets
• Biosimilars Gain from Patent Expiry of Major Drugs, Driving Gains for Bioprocess Validation Market
• Strict Safety & Quality Regulations and Compliance with cGMP for Biopharmaceuticals Support Market Growth
• Bioprocessing 4.0: Implications for Bioprocess Validation
• Validation 4.0: Essential for Sciences Industry Progresses towards Digital-First Industry
• Growing Prominence of Paperless Validation in Pharma, Biotech & Medical Devices Industries
• Bioprocess Innovations Direct Focus onto Effective & Clear Validations
• Digital Twins to Support Bioprocess Validation Market Growth
• AI-Enabled System-Led Transformations in Biomanufacturing & Bioprocess Validation
• Artificial Intelligence and Continuous Validation
• Single-Use Disposable Technologies Gain Attention
• Bioprocess Data: Critical for Improving Efficiency of Pharma Developments & Manufacturing Operations
• Advancing Process Analytical Technologies Necessitates Validation
• Process Validation for Viral Vectors: What are the Key Challenges?
• Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
• Challenges Confronting Bioprocess Validation

For more information about this report visit https://www.researchandmarkets.com/r/fczyim

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets